| Issue Date | Title | Author(s) | Type | scopus | WOS | Fulltext/Archive link |
| 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW ; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | erratum | 0 | 0 | |
| 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU ; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | erratum | 0 | 0 | |
| 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN ; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | Erratum | 0 | 0 | |
| 2019 | Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway | Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; PO-MING CHOW ; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; Huang K.-H. | journal article | 3 | 5 | |
| 2015 | MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study | Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C.; Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; SHING-HWA LIU ; Jeng Y.-M.; Huang K.-H. | journal article | 11 | | |
| 2015 | MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study | Lin W.-C.; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; Chang H.-C.; Liao S.-M.; Chou C.-T.; Chiang C.-K.; Chiu W.-S.; Chiu T.-Y.; Pu Y.-S.; Ho I.-L.; Wang Z.-H.; Chang S.-C.; Liu S.-H.; YUNG-MING JENG ; Huang K.-H. | journal article | 11 | | |
| 2019 | MLN4924, a protein neddylation inhibitor, suppresses the growth of human chondrosarcoma through inhibiting cell proliferation and inducing endoplasmic reticulum stress-related apoptosis | Wu M.-H.; Lee C.-Y.; Huang T.-J.; Huang K.-Y.; Tang C.-H.; SHING-HWA LIU ; Kuo K.-L.; Kuan F.-C.; Lin W.-C.; Shi C.-S. | journal article | 3 | 1 | |
| 2012 | Monocytic thrombomodulin triggers LPS- and gram-negative bacteria-induced inflammatory response | Ma C.-Y.; Shi G.-Y.; Shi C.-S.; Kao Y.-C.; SHU-WHA LIN ; Wu H.-L. | Journal Article | 18 | 18 | |
| 2018 | Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW ; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | journal article | 3 | 3 | |
| 2018 | Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU ; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | journal article | 3 | 3 | |
| 2018 | Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma | Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN ; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. | Journal Article | 3 | 3 | |
| 2019 | Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study | Kuo K.-L.; Liu S.-H.; Lin W.-C.; Hsu F.-S.; PO-MING CHOW ; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. | journal article | 1 | 3 | |
| 2019 | Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study | Kuo K.-L.; SHING-HWA LIU ; Lin W.-C.; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. | journal article | 1 | 3 | |
